Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Neuroimmunology

• Publication date

  2018-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jneuroim.2018.01.013PMID 29501085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review

  2017influential reference
• Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations.

  2016cited by this paper
• Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.

  2015cited by this paper
• Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus

  2011cited by this paper
• Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome.

  2009cited by this paper
• Up–Down Asymmetry of Cerebellar Activation During Vertical Pursuit Eye Movements

  2009cited by this paper
• Cyclophosphamide for anti‐GAD antibody‐positive refractory status epilepticus

  2008cited by this paper
• Reply from the authors [2]

  2007cited by this paper
• Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia

  2006cited by this paper
• Potential Role of Anti‐GAD Antibodies in Abnormal Eye Movements

  2005cited by this paper
• Vertical nystagmus: clinical facts and hypotheses.

  2005cited by this paper
• Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.

  2004cited by this paper
• Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus

  2003cited by this paper
• Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children.

  1997cited by this paper

• Paroxysmal downbeat nystagmus, a case report and a review of the literature

  2025cites this paper
• Advances in cerebellar disorders: pre-clinical models, therapeutic targets, and challenges

  2023cites this paper
• Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)

  2023cites this paper
• Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies

  2022cites this paper
• GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions

  2021cites this paper
• Paroxysmal Tremor and Vertical Nystagmus Associated with Hypomagnesemia

  2020cites this paper
• Autoimmune Vestibulocerebellar Syndromes

  2020cites this paper
• GAD antibodies in neurological disorders — insights and challenges

  2020cites this paper
• Ataxia associated with anti-glutamic acid decarboxylase antibodies

  2020cites this paper
• The neurological syndromes associated with glutamic acid decarboxylase antibodies.

  2019cites this paper
• Stiff-Person Syndrome Spectrum Disorders

  2019cites this paper
• Anti-glutamate Dehydrogenase Antibody Positive Cerebellar Ataxia and Stiff Person Syndrome Responding to Dual Treatment with Steroids and Intravenous Immunoglobulin: A Case Presentation and Literature Review

  2019cites this paper
• Stiff-Person Syndrome: A Case Report and Review of the Literature

  2019cites this paper